Literature DB >> 16581768

Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.

Naozumi Ishimaru1, Rieko Arakaki, Fumie Omotehara, Koichi Yamada, Kenji Mishima, Ichiro Saito, Yoshio Hayashi.   

Abstract

Although tissue-specific apoptosis in the exocrine glands in estrogen-deficient mice may contribute to the development of autoimmune exocrinopathy, the molecular mechanism responsible for tissue-specific apoptosis remains obscure. Here we show that RbAp48 overexpression induces p53-mediated apoptosis in the exocrine glands caused by estrogen deficiency. RbAp48-inducible transfectant results in rapid apoptosis with p53 phosphorylation (Ser9) and alpha-fodrin cleavage. Reducing the expression of RbAp48 through small interfering RNA inhibits the apoptosis. Prominent RbAp48 expression with apoptosis was observed in the exocrine glands of C57BL/6 ovariectomized (OVX) mice but not in OVX estrogen receptor alpha(-/-), p53(-/-), and E2F-1(-/-) mice. Indeed, transgenic expression of the RbAp48 gene induced apoptosis in the exocrine glands but not in other organs. These findings indicate that estrogen deficiency initiates p53-mediated apoptosis in the exocrine gland cells through RbAp48 overexpression and exerts a possible gender-based risk of autoimmune exocrinopathy in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581768      PMCID: PMC1446941          DOI: 10.1128/MCB.26.8.2924-2935.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling.

Authors:  N D Marchenko; A Zaika; U M Moll
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

Review 2.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

3.  The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein.

Authors:  E Nicolas; S Ait-Si-Ali; D Trouche
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

4.  Sex differences in autoimmune disease.

Authors:  C C Whitacre
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

5.  Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation.

Authors:  J M Paramio; C Segrelles; M L Casanova; J L Jorcano
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

6.  17beta-estradiol prevents programmed cell death in cardiac myocytes.

Authors:  T Pelzer; M Schumann; M Neumann; T deJager; M Stimpel; E Serfling; L Neyses
Journal:  Biochem Biophys Res Commun       Date:  2000-02-05       Impact factor: 3.575

7.  Protein phosphatase 1alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein.

Authors:  R H Wang; C W Liu; V I Avramis; N Berndt
Journal:  Oncogene       Date:  2001-09-27       Impact factor: 9.867

8.  Essential role for caspase-8 in transcription-independent apoptosis triggered by p53.

Authors:  H F Ding; Y L Lin; G McGill; P Juo; H Zhu; J Blenis; J Yuan; D E Fisher
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

9.  Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB.

Authors:  Q Zhang; N Vo; R H Goodman
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase.

Authors:  Jonathan H Lieman; Lori A Worley; J William Harbour
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

View more
  13 in total

1.  The enhancer of trithorax and polycomb gene Caf1/p55 is essential for cell survival and patterning in Drosophila development.

Authors:  Aimée E Anderson; Umesh C Karandikar; Kathryn L Pepple; Zhihong Chen; Andreas Bergmann; Graeme Mardon
Journal:  Development       Date:  2011-04-13       Impact factor: 6.868

Review 2.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

Review 3.  Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.

Authors:  Byung Ha Lee; Adrienne E Gauna; Kaleb M Pauley; Yun-Jong Park; Seunghee Cha
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  Mutual interdependence of MSI1 (CAC3) and YAK1 in Saccharomyces cerevisiae.

Authors:  Zachary L Pratt; Bethany J Drehman; Mary E Miller; Stephen D Johnston
Journal:  J Mol Biol       Date:  2007-01-23       Impact factor: 5.469

Review 5.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

Review 6.  Mouse Models of Primary Sjogren's Syndrome.

Authors:  Young-Seok Park; Adrienne E Gauna; Seunghee Cha
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

8.  Pleiotropic roles of the Msi1-like protein Msl1 in Cryptococcus neoformans.

Authors:  Dong-Hoon Yang; Shinae Maeng; Anna K Strain; Anna Floyd; Kirsten Nielsen; Joseph Heitman; Yong-Sun Bahn
Journal:  Eukaryot Cell       Date:  2012-10-05

Review 9.  Sjögren's syndrome: studying the disease in mice.

Authors:  Nicolas Delaleu; Cuong Q Nguyen; Ammon B Peck; Roland Jonsson
Journal:  Arthritis Res Ther       Date:  2011-06-13       Impact factor: 5.156

10.  Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Satoko Yoshida; Akiko Yamada; Sumihare Noji; Yoshio Hayashi
Journal:  J Exp Med       Date:  2008-11-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.